Retraction
RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine
Paper Information
Record ID:
42788
Journal:
Publication Date:
December 08, 2003
Retraction Date:
February 16, 2023
(2.8 years years ago)
Subjects:
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Springer - Nature Publishing Group
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (230)
230
Total Citations4
Post-Retraction(1.7%)
226
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
2
Within 1 year
1
After 2+ years
869
Days since retraction (latest)
Paper citing Single-walled carbon nanotubes-mediated in vivo an...
Unknown Authors
Unknown Journal
Published: Apr 2010
4704 days before retraction
Identifying Molecular Markers for Chemosensitivity to Gemcitabine in Pancreatic Cancer
Shinomi Ina, Seiko Hirono, Tetsuo Noda et al. (4 authors)
Pancreas
Published: Mar 2010
31 citations
31 citations
4711 days before retraction
Pharmacokinetics Of Nucleic‐Acid‐Based Therapeutics
John C. Schmitz, Aleksandra A. Pandyra, James Koropatnick et al. (4 authors)
Pharmaceutical Sciences Encyclopedia
Published: Mar 2010
1 citation
1 citation
4726 days before retraction
Gene-Based Therapies for Lung Cancer
John Nemunaitis, Jack A. Roth
Humana Press eBooks
Published: Jan 2010
1 citation
1 citation
4794 days before retraction
Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment
Hidenori Ojima, Daitaro Yoshikawa, Y Ino et al. (19 authors)
Cancer Science
Open Access
Published: Dec 2009
27 citations
27 citations
4818 days before retraction
Insight into the Mechanism of Inactivation of Ribonucleotide Reductase by Gemcitabine 5′-Diphosphate in the Presence or Absence of Reductant
Erin Artin, Jun Wang, Gregory J. S. Lohman et al. (8 authors)
Biochemistry
Open Access
Published: Nov 2009
52 citations
52 citations
4847 days before retraction
New Approaches for Cancer Treatment: Antitumor Drugs Based on gene-Targeted Nucleic Acids
Olga Patutina, Н. Л. Миронова, Valentin V. Vlassov et al. (4 authors)
Acta Naturae
Open Access
Published: Sep 2009
8 citations
8 citations
4902 days before retraction
Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer
Gabriella Ferrandina, Valentina Mey, Sara Nannizzi et al. (9 authors)
Cancer Chemotherapy and Pharmacology
Published: Jul 2009
52 citations
52 citations
4951 days before retraction
Gemcitabine-Based Chemogene Therapy for Pancreatic Cancer Using Ad-dCK::UMK GDEPT and TS/RR siRNA Strategies
Soukaina Réjiba, Christelle Bigand, C. Parmentier et al. (4 authors)
Neoplasia
Open Access
Published: Jul 2009
76 citations
76 citations
4978 days before retraction
Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications
Ivan Ischenko, Hendrik Seeliger, Axel Kleespies et al. (7 authors)
Langenbeck s Archives of Surgery
Published: May 2009
49 citations
49 citations
5034 days before retraction
Clinical pharmacology and pharmacogenetics of gemcitabine
Andrea Li‐Ann Wong, Ross A. Soo, Wei Peng Yong et al. (4 authors)
Drug Metabolism Reviews
Published: May 2009
157 citations
157 citations
5039 days before retraction
Gene expression profiling identifies novel key players involved in the cytotoxic effect of Artesunate on pancreatic cancer cells
Mаhmoud Youns, Thomas Efferth, Jürgen Reichling et al. (6 authors)
Biochemical Pharmacology
Open Access
Published: Apr 2009
85 citations
85 citations
5047 days before retraction
Concepts in in vivo siRNA delivery for cancer therapy
Christopher S. Gondi, Jasti S. Rao
Journal of Cellular Physiology
Open Access
Published: Apr 2009
75 citations
75 citations
5047 days before retraction
Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug
Julie Guillermet‐Guibert, Lise Davenne, Dmitri Pchejetski et al. (10 authors)
Molecular Cancer Therapeutics
Open Access
Published: Apr 2009
135 citations
135 citations
5069 days before retraction
Potent subunit-specific effects on cell growth and drug sensitivity from optimised siRNA-mediated silencing of ribonucleotide reductase.
Glen Reid, Natacha Coppieters, Rachna Patel et al. (8 authors)
PubMed
Published: Mar 2009
32 citations
32 citations
5092 days before retraction
Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesis
Keqiang Zhang, Shuya Hu, Jun Wu et al. (9 authors)
Molecular Cancer
Open Access
Published: Feb 2009
97 citations
97 citations
5101 days before retraction
A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503
Anne M. Traynor, Ju-Whei Lee, Gerald K. Bayer et al. (9 authors)
Investigational New Drugs
Open Access
Published: Feb 2009
108 citations
108 citations
5106 days before retraction
A TaqMan Low-Density Array to Predict Outcome in Advanced Hodgkin's Lymphoma Using Paraffin-Embedded Samples
Beatriz Sánchez‐Espiridión, Abel Sánchez‐Aguilera, Carlos Montalbán et al. (20 authors)
Clinical Cancer Research
Open Access
Published: Feb 2009
38 citations
38 citations
5114 days before retraction
Paper citing RNA interference targeting the M2 subunit of ribon...
Unknown Authors
Unknown Journal
Published: Feb 2009
5120 days before retraction
Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography
Rachel E. Laing, Martin A. Walter, Dean O. Campbell et al. (9 authors)
Proceedings of the National Academy of Sciences
Open Access
Published: Feb 2009
53 citations
53 citations
5122 days before retraction
Allele-specific cancer cell killing in vitro and in vivo targeting a single-nucleotide polymorphism in POLR2A
Olaf R.F. Mook, Frank Baas, Marit B. de Wissel et al. (4 authors)
Cancer Gene Therapy
Published: Jan 2009
21 citations
21 citations
5137 days before retraction
Nucleosides, Nucleotides and Nucleic Acids
Ashraf Al Madhoun, Staffan Eriksson, Zhixian Wang et al. (6 authors)
Unknown Journal
Published: Jan 2009
4 citations
4 citations
5159 days before retraction
Low dose rotenone treatment causes selective transcriptional activation of cell death related pathways in dopaminergic neurons in vivo
Bernhard H. Meurers, Chunni Zhu, Pierre‐Olivier Fernagut et al. (11 authors)
Neurobiology of Disease
Open Access
Published: Oct 2008
32 citations
32 citations
5225 days before retraction
Molecular Analysis of Stem Cells and Their Descendants during Cell Turnover and Regeneration in the Planarian Schmidtea mediterranea
George T. Eisenhoffer, Hara Kang, Alejandro Sánchez Alvarado
Cell stem cell
Open Access
Published: Sep 2008
410 citations
410 citations
5281 days before retraction
Down-regulation of deoxycytidine kinase enhances acquired resistance to gemcitabine in pancreatic cancer.
Seiji Ohhashi, Kenoki Ohuchida, Kazuhiro Mizumoto et al. (10 authors)
PubMed
Published: Aug 2008
106 citations
106 citations
5283 days before retraction
Molecular Imaging Study on<i>In Vivo</i>Distribution and Pharmacokinetics of Modified Small Interfering RNAs (siRNAs)
Thomas Viel, Raphaël Boisgard, Bertrand Kühnast et al. (8 authors)
Oligonucleotides
Published: Aug 2008
44 citations
44 citations
5286 days before retraction
Pharmacogenetics in oncology
Romano Danesi, Antonello Di Paolo, Guido Bocci et al. (5 authors)
European Journal of Cancer Supplements
Open Access
Published: Aug 2008
1 citation
1 citation
5294 days before retraction
Integrated Bioinformatics for Radiation-Induced Pathway Analysis from Proteomics and Microarray Data
Zhang-Zhi Hu, Hongzhan Huang, Amrita K. Cheema et al. (6 authors)
Journal of Proteomics & Bioinformatics
Open Access
Published: May 2008
27 citations
27 citations
5381 days before retraction
Anticancer activity of RecQL1 helicase siRNA in mouse xenograft models
Kazunobu Futami, Emi Kumagai, Hiroshi Makino et al. (7 authors)
Cancer Science
Published: Apr 2008
47 citations
47 citations
5421 days before retraction
Cyclopentenyl cytosine increases gemcitabine radiosensitisation in human pancreatic cancer cells
Chris van Bree, Hans M. Rodermond, René Leen et al. (5 authors)
British Journal of Cancer
Open Access
Published: Mar 2008
4 citations
4 citations
5448 days before retraction
Molecular mechanisms of drug resistance, invasion and metastasis in pancreatic carcinoma
Naomi Walsh
Unknown Journal
Published: Mar 2008
5465 days before retraction
RNA interference‐mediated silencing of the <i>polo‐like kinase 1</i> gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells
Chunzhao Yu, X. Zhang, Guangyong Sun et al. (17 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Feb 2008
30 citations
30 citations
5489 days before retraction
Gemcitabine
Andries M. Bergman, Godefridus J. Peters
Humana Press eBooks
Published: Nov 2007
1 citation
1 citation
5581 days before retraction
Antimetabolites
Janet A. Houghton
Humana Press eBooks
Published: Oct 2007
1 citation
1 citation
5599 days before retraction
Survival prediction of stage I lung adenocarcinomas by expression of 10 genes
Fabrizio Bianchi, Paolo Nucíforo, Manuela Vecchi et al. (10 authors)
Journal of Clinical Investigation
Open Access
Published: Oct 2007
112 citations
112 citations
5599 days before retraction
<scp>RNA</scp>Interference
Charlotte Moss, Nicholas R. Lemoine
The Cancer Handbook
Published: Oct 2007
5608 days before retraction
Progress in the Development of Prognostic and Predictive Markers for Gastrointestinal Malignancies
Crystal S. Denlinger, Steven J. Cohen
Current Treatment Options in Oncology
Published: Oct 2007
23 citations
23 citations
5617 days before retraction
Effects of tumor selective replication-competent herpes viruses in combination with gemcitabine on pancreatic cancer
Izuru Watanabe, Hideki Kasuya, Naohiro Nomura et al. (10 authors)
Cancer Chemotherapy and Pharmacology
Published: Aug 2007
39 citations
39 citations
5651 days before retraction
Human equilibrative nucleoside transporter 1, as a predictor of 5-fluorouracil resistance in human pancreatic cancer.
Masanori Tsujie, Shoji Nakamori, Shin Nakahira et al. (11 authors)
PubMed
Published: Aug 2007
58 citations
58 citations
5660 days before retraction
Review of recent studies on resistance to cytotoxic deoxynucleoside analogues
Lars Petter Jordheim, Charles Dumontet
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Published: Aug 2007
85 citations
85 citations
5664 days before retraction
Will cyclopentenyl cytosine (CPEC) ever have a future in the clinic?
Chris van Bree, André B. P. Kuilenburg
Leukemia Research
Published: Aug 2007
3 citations
3 citations
5671 days before retraction
Antimetabolites
Kenneth Wyman, Igor Puzanov, Kenneth R. Hande
Birkhäuser Basel eBooks
Published: Jun 2007
5728 days before retraction
RNAi-mediated knockdown of target genes: a promising strategy for pancreatic cancer research
Hong Chang
Cancer Gene Therapy
Published: Jun 2007
31 citations
31 citations
5739 days before retraction
Ribonucleotide reductase subunit M2 mRNA expression in pretreatment biopsies obtained from unresectable pancreatic carcinomas
Takao Itoi, Atsushi Sofuni, Noriyoshi Fukushima et al. (9 authors)
Journal of Gastroenterology
Published: May 2007
76 citations
76 citations
5746 days before retraction
Potent siRNA Inhibitors of Ribonucleotide Reductase Subunit RRM2 Reduce Cell Proliferation <i>In vitro</i> and <i>In vivo</i>
Jeremy D. Heidel, Joanna Yi-Ching Liu, Yun Yen et al. (8 authors)
Clinical Cancer Research
Open Access
Published: Apr 2007
159 citations
159 citations
5800 days before retraction
An increase of cytochrome C oxidase mediated disruption of gemcitabine incorporation into DNA in a resistant KB clone
Xiyong Liu, Bingsen Zhou, Shu Mi et al. (9 authors)
Biochemical Pharmacology
Open Access
Published: Mar 2007
5 citations
5 citations
5811 days before retraction
RNA interference targeting the R2 subunit of ribonucleotide reductase inhibits growth of tumor cells in vitro and in vivo
Tina Avolio, Yoon Lee, Ningping Feng et al. (9 authors)
Anti-Cancer Drugs
Published: Feb 2007
14 citations
14 citations
5834 days before retraction
RNA Interference in Mice
Ralf Kühn, Stefan Streif, Wolfgang Wurst
Springer eBooks
Published: Feb 2007
31 citations
31 citations
5858 days before retraction
The synergistic interaction of gemcitabine and cytosine arabinoside with the ribonucleotide reductase inhibitor triapine is schedule dependent
J. Sigmond, J. A. E. Kamphuis, Adrianus C. Laan et al. (6 authors)
Biochemical Pharmacology
Published: Jan 2007
25 citations
25 citations
5869 days before retraction
RNA interference: Implications for cancer treatment
Massimo Masiero, Giorgia Nardo, Stefano Indraccolo et al. (4 authors)
Molecular Aspects of Medicine
Published: Jan 2007
73 citations
73 citations
5878 days before retraction
Quick Stats
Total Citations:
230
Years Since Retraction:
2.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025